Brussels will extend until the end of December its mechanism for controlling exports of EUCOVID-19 vaccines produced in the EU, in order to guarantee supplies to member states in the face of uncertainties driven by the emergence of new variants, the European Commission announced today .
“While vaccination campaigns across the EU have accelerated over the months, ‘they are still ongoing and uncertainties continue, especially with the emergence of new variants of the virus,'” the EC said in a statement.
“Therefore, it is necessary to maintain transparency, and the control mechanism, valid until the end of September, will be extended until December 31. “No extension is planned beyond this date,” he added.
The EU executive set up at the end of January a mechanism to authorize vaccine exports, to control trade in countries where the health situation was considered better than in Europe, and, in particular, to monitor deliveries to the AstraZeneca laboratory, accused that it did not comply with orders received from member states for the benefit of other countries.
This has not prevented the EU from exporting nearly 740 million doses since that date.
In practice, this mechanism requires, before any export of vaccines outside the EU from a laboratory, to receive the green light from the Member State from which the doses are distributed.
This decision must be confirmed by the Commission.//ATSH
To be part of the group »AOL“just click: Join Group and your request will be approved immediately.